Diabetes Education App for Type 2 Diabetes
Trial Summary
The trial does not specify whether you need to stop taking your current medications. However, participants in both study groups will continue their routine follow-up care with their primary care physicians, which suggests you may continue your current medications.
Research shows that using internet and technology-based tools for diabetes education can improve patient outcomes by providing personalized support and helping patients manage their condition more effectively. These tools allow patients to track their health data, receive timely feedback, and connect with healthcare providers and support networks, which can lead to better self-management and improved health outcomes.
12345The available research does not provide specific safety data for the Diabetes Education App for Type 2 Diabetes, but similar apps have been tested for usability and feasibility, showing they are generally well-received and promote positive health behaviors.
678910The Diabetes Education App for Type 2 Diabetes is unique because it provides an interactive and educational platform for self-management, using a mobile or web application to help users learn about and manage their condition effectively. Unlike traditional treatments that may focus solely on medication, this app emphasizes education and self-efficacy, offering tools like quizzes and a diabetes dictionary to enhance users' understanding and control of their diabetes.
610111213Eligibility Criteria
This trial is for adults over 18 with uncontrolled Type 2 Diabetes (HA1c >8.0) who are patients at the Family Healthcare Center, Reading Hospital Tower Health. It's not for pregnant individuals, incarcerated people, those without a smartphone, or anyone unable to consent.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the intervention arm use the diabetes education app for 6 months, while control arm participants continue routine care
Follow-up
Participants are monitored for changes in HA1C, blood pressure, BMI, and self-efficacy for diabetes management